BRCA1 -like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial-论文-万方医学网

BRCA1 -like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial

导出原文传递

翻译打印收藏纠错

作者： A. G. J. van Rossum ^[1] ; P. C. Schouten ^[2] ; K. E. Weber ^[3] ; V. Nekljudova ^[4] ; C. Denkert ^[5] ; C. Solbach ^[6] ; C. H. K?hne ^[7] ; C. Thomssen ^[8] ; H. Forstbauer ^[9] ; G. Hoffmann ^[10] ; A. Kohls ^[11] ; S. Schmatloch ^[12] ; C. Schem ; G. von Minckwitz ; T. Karn ; V. J. M?bus ; S. C. Linn ; S. Loibl ; F. Marmé

作者单位： German Breast Group ^[1] Charité - Universit?tsmedizin ^[2] University Women’s Hospital ^[3] University Clinic for Internal Medicine Oncology and Hematology ^[4] University Halle Wittenberg ^[5] Gesellschaft für onkologische Studien ^[6] St. Josefs-Hospital ^[7] Ev. Krankenhaus ^[8] Elisabeth Krankenhaus ^[9] Women’s Hospital, University of Kiel ^[10] Netherlands Cancer Institute ^[11] Center for Gynecological Oncology at University Women’s Hospital ^[12]

关键词 BRCA1-like Profile Non-myeloablative Intensified Chemotherapy

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除